626 related articles for article (PubMed ID: 10685325)
1. Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.
Onadeko BO; Khadadah ME; Mustafa HT; Ezeamuzie CI; Marouf R; Khamis A; Sugathan TN
East Afr Med J; 1999 Sep; 76(9):524-9. PubMed ID: 10685325
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil cationic protein as a serological marker of disease activity in childhood bronchial asthma.
Badr-el-Din OM; el-Sawy IH; el-Azzouni OE; Badr-el-Din MM; Salem AM
East Mediterr Health J; 1999 Jul; 5(4):664-75. PubMed ID: 11338688
[TBL] [Abstract][Full Text] [Related]
3. Manifold significance of serum eosinophil cationic protein in asthmatic children.
Zubović I; Rozmanić V; Ahel V; Banac S
Acta Med Croatica; 2002; 56(2):53-6. PubMed ID: 12596625
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of blood eosinophilia and the eosinophil cationic protein (ECP) in the serum of asthmatic children with varying degree of severity.
Vilá-Indurain B; Muñoz-López F; Martín-Mateos M
Allergol Immunopathol (Madr); 1999; 27(6):304-8. PubMed ID: 10611555
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course.
Skedinger M; Halldén G; Lundahl J; Hed J; Zetterström O
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):250-5. PubMed ID: 7552927
[TBL] [Abstract][Full Text] [Related]
6. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
8. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
Ferdousi HA; Dreborg S
Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
[TBL] [Abstract][Full Text] [Related]
9. Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity.
Fujitaka M; Kawaguchi H; Kato Y; Sakura N; Ueda K; Abe Y
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):323-9. PubMed ID: 11289333
[TBL] [Abstract][Full Text] [Related]
10. [Eosinophil cationic protein in serum from adults with asthma and with chronic obstructive pulmonary disease].
Yoshizawa A; Kamimura M; Sugiyama H; Kudo K; Kabe J
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):24-9. PubMed ID: 8717287
[TBL] [Abstract][Full Text] [Related]
11. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
Wever AM; Wever-Hess J; Hermans J
Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
[TBL] [Abstract][Full Text] [Related]
12. [Eosinophil cationic protein in patients with bronchial asthma].
Numao T; Fukuda T; Hirata A; Sagara H; Majima K; Nakajima H; Akutsu I; Ando N; Makino S
Arerugi; 1991 Feb; 40(2):93-9. PubMed ID: 1712583
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of serum eosinophil cationic protein levels in bronchial asthma].
Hasegawa M; Fujisawa T; Komada M; Uchida Y; Haibara C
Arerugi; 1991 Mar; 40(3 Pt 1):173-80. PubMed ID: 2053855
[TBL] [Abstract][Full Text] [Related]
14. Serum eosinophil cationic protein measurements in the management of perennial and periodic asthma: a prospective study.
de Blay F; Purohit A; Stenger R; Gries P; Hamberger C; David B; Frossard N; Pauli G
Eur Respir J; 1998 Mar; 11(3):594-8. PubMed ID: 9596108
[TBL] [Abstract][Full Text] [Related]
15. [A basic study on the plasma and serum levels of eosinophil cationic protein (ECP) in bronchial asthma].
Yasuba H; Satake N; Kino T; Izumi T; Kawaguchi H
Arerugi; 1991 Oct; 40(10):1282-8. PubMed ID: 1772351
[TBL] [Abstract][Full Text] [Related]
16. Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function.
Jahnz-Ró yk K; Plusa T; Mierzejewska J
Mediators Inflamm; 2000; 9(3-4):175-9. PubMed ID: 11132775
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy.
Scher H; Berman D; Weinberg EG; Schinkel M; Peper B; Chalton DO; Potter PC
Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698
[TBL] [Abstract][Full Text] [Related]
18. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis.
Oh JW; Shin JC; Jang SJ; Lee HB
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma.
Schmekel B; Ahlner J; Malmström M; Venge P
Respir Med; 2001 Aug; 95(8):670-5. PubMed ID: 11530956
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
